Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Clinical Trials on Drug Hypersensitivity in India
Total 0 results
Nothing found
Sponsors and Collaborators
Steven B. Kleiboeker
The Institute of Neuropsychiatry and Addictions (INAD), Parc de Salut Mar, Barcelona
Saw Swee Hock School of Public Health
Hospital Governador Celso Ramos
Pharmacy Board of Sierra Leone, Ministry of Health and Sanitation
Shenzhen Core Medical Technology CO.,LTD.
Didem OZKAL EMINOGLU
Sociedad Panameña de Hematología
Donald B. Kohn, M.D.
Sub-Investigator: Łucja Bieleninik, PhD
Centre Hospitalier du Quebec
Nelson Mandela Academic Hospital
Roongroj Bhidayasiri
Dr. Jochen Brack
Worabe Comprehensive Specialiazed Hospital
Pompeyo Stalin Alarcón Vigil
MYOR Ltd.
Shaoxing Mashan Street Community Health Service Center
Maria de las Mercedes Perez Rodriguez
Universidad Mayor de San Simón (UMSS, Bolivia)
View Full List
Medical Conditions
Atherosclerosis Coronary Artery With Angina Pectoris
Endoscopic Surveillance
Small Intestine Cancer
Bladder Recurrence
Inoperable Stage III Non-small Cell Lung Cancer
0.5-14 Year Old Children With Nephroblastoma
Control Nausea and Vomiting
Neuroectodermal Tumor
Urinary Bladder Neurogenic Dysfunction
Poor Medication Adherence
Humerus Fracture Displaced Proximal
Macrocephaly Autism Syndrome
Granulomatous Disease, Chronic
Anticoagulant Prophylaxis/Therapy
Root Abscess
Malignant Tumor of Urinary System (Disorder)
Memory Disorders
Parental
Bladder Cancer Recurrent
Pharmacokinetics of Ipragliflozin
View Full List
Drug Interventions
Bupropion Extended Release Oral Tablet
Ceralasertib
Cyclosporine A
Fibrin Sealant
Clozapine 100 mg
Idelalisib
FTD regimen
Campath 1H
Salvinorin A
APG2575 800 mg
Everolimus
Biphasic insulin aspart 30
Varenicline Controlled Release 1.2 mg
The drug "Rutan 0.1".
Elafibranor 80mg
Letrozole
Sparsentan
Rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days)
Vehicle
SAR408701 (Tusamitamab ravtansine)
View Full List
CROs by country
Contract Research Organizations in Congo, DR of
Contract Research Organizations in Cote d'Ivoire
Contract Research Organizations in Ecuador
Contract Research Organizations in Gabon
Contract Research Organizations in Greece
Contract Research Organizations in Kenya
Contract Research Organizations in Macedonia
Contract Research Organizations in Mongolia
Contract Research Organizations in Morocco
Contract Research Organizations in Norway
Contract Research Organizations in Russia
Contract Research Organizations in Saint Lucia
Contract Research Organizations in Spain
CRO list by country
CROs in New Zealand
IQVIA
Premier Research
P3 Research
Fortrea
SGS
ICON
GreenLight Clinical
Novotech
PPD
All CROs in New Zealand
3
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe